SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-052204
Filing Date
2007-03-12
Accepted
2007-03-12 16:15:18
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 702718
2 STOCK PLAN, NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AGREEMENT AS AMENDED dex104.htm EX-10.4 113018
3 SUBSIDIARIES dex211.htm EX-21.1 1445
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1523
5 CERTIFICATION dex311.htm EX-31.1 5964
6 CERTIFICATION dex312.htm EX-31.2 5865
7 CERTIFICATION dex321.htm EX-32.1 2603
8 CERTIFICATION dex322.htm EX-32.2 2651
  Complete submission text file 0001193125-07-052204.txt   837279
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51462 | Film No.: 07687825
SIC: 2836 Biological Products, (No Diagnostic Substances)